# Title

 Food and Drugs. PART 329â€”NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT


# ID

 CFR-2018-title21-vol5.Pt. 329


# Structured Analysis Summary

| Type        | Values                       |
|:------------|:-----------------------------|
| Constraints | ['within', 'after']          |
| Duration    | ['15.0 day']                 |
| Condition   | ['subject to', 'if', 'when'] |
| Entities    | ['Food', 'Unique']           |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                 |
|:--------------|:------------------------------------------------------------------------------------------------------------------------|
| after         | nonprescription product; (vii) Whether adverse drug event abated after drug use stopped or dose reduced; (viii) Whether |
| after         | nonprescription product; (vii) Whether adverse drug event abated after drug use stopped or dose reduced; (viii) Whether |
| within        | by a copy of the label on or within the retail package of the drug and any                                              |


## Duration

| Duration   | Context                                                                                                                                  |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------|
| 15.0 day   | (i) Name and contact office address;                                                                                                     |
|            |             (ii) Telephone number;                                                                                                       |
|            |             (iii) Report source, such as spontaneous;                                                                                    |
|            |             (iv) Date the report was received by responsible person;                                                                     |
|            |             (v) Whether the ICSR is a 15-day report;                                                                                     |
|            |             (vi) Whether the ICSR is an initial report or followup report; and                                                           |
|            |             (vii) Unique case identification number, which must be the same in the initial report and any subsequent followup report(s). |


## Condition

| Condition   | Context                                                                              |
|:------------|:-------------------------------------------------------------------------------------|
| subject to  | OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT. subject to                              |
| if          | is a health care professional; and (iii) Occupation, if  a health care professional. |
| when        | as part of the initial reporter information, even when  the reporter is the patient. |


## Entities

| Entities   | Context                                                                                                   |
|:-----------|:----------------------------------------------------------------------------------------------------------|
| Food       | Food  and Drugs.                                                                                          |
| Unique     | an initial report or followup report; and (vii) Unique case identification number, which must be the same |


